Skip to main content
. 2021 Aug 18;9(1):1966187. doi: 10.1080/20016689.2021.1966187

Table 3.

Sensitivity analysis of 5% variation in model inputs

  Cost/QALY Low Cost/QALY High Cost-effectiveness
reSET-O Cost -$92,542.43 -$80,272.49 economically dominant (less costly, more effective)
Buprenorphine cost -$86,407.46 -$86,407.46
Cost of CM -$84,916.33 -$87,898.60
Costs not retained -$78,615.80 -$94,199.13
Utilities Retained -$182,980.51 -$41,753.94
Utilities Not Retained -$44,122.96 -$2,073,779.14